Franklin Resources’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$172K Sell
10,268
-670
-6% -$12K ﹤0.01% 2822
2025
Q4
$175K Sell
10,938
-8,433
-44% -$126K ﹤0.01% 2820
2025
Q3
$239K Sell
19,371
-4,397
-18% -$51.5K ﹤0.01% 2761
2025
Q2
$274K Sell
23,768
-3,791
-14% -$45K ﹤0.01% 2599
2025
Q1
$413K Buy
27,559
+782
+3% +$13.1K ﹤0.01% 2342
2024
Q4
$464K Buy
+26,777
New +$517K ﹤0.01% 2320
2019
Q4
Sell
-1,165,690
Closed -$54.3M 1536
2019
Q3
$54.3M Buy
1,165,690
+18,470
+2% +$859K 0.03% 514
2019
Q2
$60M Buy
1,147,220
+320,165
+39% +$18.8M 0.03% 506
2019
Q1
$57M Buy
827,055
+87,215
+12% +$5.85M 0.03% 499
2018
Q4
$44.1M Buy
739,840
+268,240
+57% +$23.1M 0.03% 503
2018
Q3
$54.6M Buy
471,600
+10,600
+2% +$1.2M 0.03% 516
2018
Q2
$58.2M Sell
461,000
-9,800
-2% -$1.19M 0.03% 495
2018
Q1
$51M Sell
470,800
-19,466
-4% -$2.15M 0.03% 527
2017
Q4
$53.7M Buy
490,266
+12,866
+3% +$1.28M 0.03% 516
2017
Q3
$47.1M Buy
477,400
+116,300
+32% +$11.3M 0.02% 549
2017
Q2
$36.6M Sell
361,100
-73,105
-17% -$7.88M 0.02% 621
2017
Q1
$50.2M Sell
434,205
-197,400
-31% -$22.9M 0.03% 518
2016
Q4
$75.8M Buy
631,605
+51,600
+9% +$5.71M 0.04% 422
2016
Q3
$65.2M Buy
580,005
+7,500
+1% +$864K 0.03% 448
2016
Q2
$70.9M Sell
572,505
-27,595
-5% -$3.33M 0.04% 436
2016
Q1
$67.5M Buy
600,100
+1,600
+0.3% +$166K 0.04% 448
2015
Q4
$65.1M Buy
598,500
+28,800
+5% +$3.3M 0.03% 479
2015
Q3
$56.9M Buy
569,700
+58,100
+11% +$6.32M 0.03% 515
2015
Q2
$58.3M Buy
+511,600
New +$62M 0.03% 551
2014
Q4
Sell
-50,000
Closed -$7.32M 1578
2014
Q3
$7.32M Sell
50,000
-25,000
-33% -$3.86M ﹤0.01% 1104
2014
Q2
$12.5M Buy
75,000
+4,900
+7% +$872K 0.01% 1005
2014
Q1
$13.9M Buy
70,100
+20,000
+40% +$3.78M 0.01% 947
2013
Q4
$9.57M Hold
50,100
﹤0.01% 996
2013
Q3
$8.48M Buy
50,100
+100
+0.2% +$15.5K ﹤0.01% 1013
2013
Q2
$7.58M Buy
+50,000
New +$7.08M ﹤0.01% 1005

Other funds holding CLB

Franklin Resources's CLB Position: Q1 2026 in Review

Franklin Resources reduced its Core Laboratories (CLB) stake by 6.1% in Q1 2026, selling an estimated $12K and leaving 10,268 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #2822.

Franklin Resources first reported a position in CLB in Q2 2013 and has held it in 30 quarters since. The position peaked at $75.8M in Q4 2016. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Franklin Resources held 10,268 shares of Core Laboratories worth $172K as of Q1 2026.
  • Franklin Resources sold 670 Core Laboratories shares in Q1 2026, an estimated $12K.
  • Core Laboratories made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2822 holding.
  • Franklin Resources first reported a position in Core Laboratories in Q2 2013 and has held it in 30 quarters since.
  • Franklin Resources's Core Laboratories position peaked at $75.8M in Q4 2016.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.